CTRI/2020/08/027009已完成3 期
A Clinical Study to Evaluate the role of Herbal Immunomodulators(sriveda sattva Pvt Ltd)in Boosting the Immunity among Health Care Workers assigned to COVID-19 Wards.
Sriveda Sattva Private Limited Sri Sri Tattva0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.Participants willing to give written informed consent.(Annexure 1)
- •2.Participants of either sex aged between 18 and 60 years.
- •3.Health care workers -Nurses
排除标准
- •Participants who are not willing to give consent for the study.
- •2. Participants with comorbidities like Hypertension, Type 1 or 2 Diabetes mellitus,
- •3. Participants suffering from chronic conditions affecting any of the major organs such as, Liver, Kidney, heart and Lungs
- •4. Pregnant women/lactating mothers
- •5. Participants on immunosuppressants
研究者
相似试验
已完成
2 期
Role of Herbal Immunomodulators in mild COVID-19 confirmed casesCTRI/2020/06/025801The Himalaya Drug Company40
已完成
3 期
se of Herbal Medicine likeTulasi,Amruth(Giloy), Turmeric,Ashwagandha as add on treatment in COVID-19 PatientsCTRI/2020/06/025592Sri Sri Tattva40
已完成
不适用
Ayurvedic Proprietary Medicine (VIRANORM) clinical trial on COVID-19 patientsCTRI/2020/09/028158K Wellness
招募中
2 期
Study on herbal neutraceuticals in delivering physical energyCTRI/2023/02/049575MVR Ayurveda medical college and hospital
尚未招募
2 期
Evaluation of herbal regimens in adults with acute/chronic pain and inflammatioCTRI/2023/07/055431BVG life Sciences Limited